Charles River Laboratories International (CRL)
(Real Time Quote from BATS)
$167.75 USD
+0.84 (0.50%)
Updated Aug 4, 2025 11:02 AM ET
2-Buy of 5 2
B Value B Growth C Momentum A VGM
Fundamental Charts
About Dividend Yield (TTM)
Charles River Laboratories International, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical Services industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
CRL 167.75 +0.84(0.50%)
Will CRL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CRL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CRL
Analysts Estimate AMN Healthcare Services (AMN) to Report a Decline in Earnings: What to Look Out for
Charles River Laboratories (CRL) Expected to Beat Earnings Estimates: Should You Buy?
CRL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Charles River Q2 Earnings Preview: What's in Store for the Stock?
Will Charles River (CRL) Beat Estimates Again in Its Next Earnings Report?
Is it Prudent to Retain Charles River Stock in Your Portfolio Now?
Other News for CRL
CRL Crosses Below Key Moving Average Level
Charles River (CRL) Explores New Partnership for Funding Opportunities
Charles River, BioTech Social to pursue crowdfunding partnership
Charles River and BioTech Social Inc. Pursue Crowdfunding Partnership | CRL Stock News
ClearBridge Growth Fund Q2 2025 Commentary